Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer’s disease in the UK using MMSE- and ADL-based models

Publication Type:
Journal Article


Citation:

Nagy B, Brennan A, Brandtmuller A, Thomas SK, Sullivan SD and Akehurst R. Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer’s disease in the UK using MMSE- and ADL-based models. Int J Geriatr Psychiatry. 2011;26(5):483-94.

 


Link to publication ⟶

⟵ Back to Search Results